ATC code C05
| ATC codes |
|---|
| C Cardiovascular system |
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin-angiotensin system |
| C10 Lipid modifying agents |
|
A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V |
ATC code C05 Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC05...[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents |
[edit] C05A Agents for treatment of hemorrhoids and anal fissures for topical use
[edit] C05AA Corticosteroids
- C05AA01 Hydrocortisone
- C05AA04 Prednisolone
- C05AA05 Betamethasone
- C05AA06 Fluorometholone
- C05AA08 Fluocortolone
- C05AA09 Dexamethasone
- C05AA10 Fluocinolone acetonide
- C05AA11 Fluocinonide
- C05AA12 Triamcinolone
[edit] C05AB Antibiotics
[edit] C05AD Local anesthetics
- C05AD01 Lidocaine
- C05AD02 Tetracaine
- C05AD03 Benzocaine
- C05AD04 Cinchocaine
- C05AD05 Procaine
- C05AD06 Oxetacaine
- C05AD07 Pramocaine
[edit] C05AE Muscle relaxants
- C05AE01 Glyceryl trinitrate
- C05AE02 Isosorbide dinitrate
[edit] C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
- C05AX01 Aluminium preparations
- C05AX02 Bismuth preparations, combinations
- C05AX03 Other preparations, combinations
- C05AX04 Zinc preparations
- C05AX05 Tribenoside
[edit] C05B Antivaricose therapy
[edit] C05BA Heparins or heparinoids for topical use
- C05BA01 Organo-heparinoid
- C05BA02 Sodium apolate
- C05BA03 Heparin
- C05BA04 Pentosan polysulfate sodium
- C05BA51 Heparinoid, combinations
- C05BA53 Heparin, combinations
[edit] C05BB Sclerosing agents for local injection
- C05BB01 Monoethanolamine oleate
- C05BB02 Polidocanol
- C05BB03 Invert sugar
- C05BB04 Sodium tetradecyl sulfate
- C05BB05 Phenol
- C05BB56 Glucose, combinations
[edit] C05BX Other sclerosing agents
- C05BX01 Calcium dobesilate
- C05BX51 Calcium dobesilate, combinations
[edit] C05C Capillary stabilising agents
[edit] C05CA Bioflavonoids
- C05CA01 Rutoside
- C05CA02 Monoxerutin
- C05CA03 Diosmin
- C05CA04 Troxerutin
- C05CA05 Hidrosmin
- C05CA51 Rutoside, combinations
- C05CA53 Diosmin, combinations
- C05CA54 Troxerutin, combinations
[edit] C05CX Other capillary stabilising agents
- C05CX01 Tribenoside
- C05CX02 Naftazone
- C05CX03 Hippocastani semen
[edit] References
- ^ "ATC/DDD Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/.
- ^ "ATCvet Index 2011". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/.
|
||||||||||||||||
